StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Saturday. The firm issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Price Performance
Shares of NYSE BTX opened at $1.96 on Friday. The company’s 50 day simple moving average is $2.15 and its 200 day simple moving average is $1.80. Brooklyn ImmunoTherapeutics has a fifty-two week low of $0.17 and a fifty-two week high of $10.10. The firm has a market capitalization of $115.30 million, a P/E ratio of -0.86 and a beta of 4.61.
Brooklyn ImmunoTherapeutics Company Profile
See Also
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- How to Calculate Return on Investment (ROI)
- Charles Schwab Fortifies its Uptrend on EPS Beat
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.